Cognitive impairment and general anaesthesia - Case report
- PMID: 20562790
Cognitive impairment and general anaesthesia - Case report
Abstract
Degeneration of cholinergic receptors causes memory disorders and irreversible impairment in cognitive functions, whose advancement can lead to clinically recognizable Alzheimer's disease (AD). Very often, the first symptoms of AD are mood swings and hence depression should be excluded by differential diagnosis since it can also cause memory disorders and cognitive deficits. Due to the characteristic clinical picture of AD, its diagnosis should not be a problem, except at the very beginning of the disease. Many AD patients are never diagnosed and therefore are not adequately treated in clinical practice. Agents used for general anaesthesia reduce cholinergic transmission, which is manifested by loss of consciousness, pain, voluntary movements and memory. In patients with compromised memory and cognitive functionality, general anaesthesia can postoperatively have an adverse effect on the prognosis of degenerative cerebral disease. A patient is described whose preoperative impaired memory and cognitive functioning deteriorated after general anaesthesia and whose clinical picture reached the extent of AD.
Similar articles
-
Differential neuropsychological patterns of frontal variant frontotemporal dementia and Alzheimer's disease in a study of diagnostic concordance.Neuropsychologia. 2008 Apr;46(5):1495-504. doi: 10.1016/j.neuropsychologia.2007.12.023. Epub 2008 Jan 5. Neuropsychologia. 2008. PMID: 18262206
-
Multiple cognitive deficits during the transition to Alzheimer's disease.J Intern Med. 2004 Sep;256(3):195-204. doi: 10.1111/j.1365-2796.2004.01386.x. J Intern Med. 2004. PMID: 15324363 Review.
-
[Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].Encephale. 2003 May-Jun;29(3 Pt 1):266-72. Encephale. 2003. PMID: 12876552 French.
-
Prodromal Alzheimer's disease: successive emergence of the clinical symptoms.Ann Neurol. 2008 Nov;64(5):492-8. doi: 10.1002/ana.21509. Ann Neurol. 2008. PMID: 19067364
-
Mild cognitive impairment: an opportunity to identify patients at high risk for progression to Alzheimer's disease.Clin Ther. 2006 Jul;28(7):991-1001. doi: 10.1016/j.clinthera.2006.07.006. Clin Ther. 2006. PMID: 16990077 Review.
Cited by
-
Tetramethylpyrazine protects neural stem cells against sevoflurane-induced toxicity through Akt/GSK-3β pathway.Metab Brain Dis. 2022 Oct;37(7):2457-2466. doi: 10.1007/s11011-022-01008-2. Epub 2022 Jul 15. Metab Brain Dis. 2022. PMID: 35838869
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical